HIGHLIGHTS
- who: C. Mann from the We analyzed retrospectively , patients from January , December , who underwent either total minimally invasive or robot assisted minimally invasive esophagectomy in our center, University medical center of the Johannes-Gutenberg-University Mainz, GermanyIncluded were all patients operated for cancer at any stage, tumor location, histological entity, or possible application of neoadjuvant therapy. Patients with distant metastases (of adenocarcinoma or squamous cell carcinoma) or benign underlying disease were excluded since tumor infiltration of LPL was of the main interest in this study. Patients were allocated in two groups depending on the extent of lymph . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.